EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Impact of Intensive Glycemic Treatment on Diabetes Complications—A Systematic Review

Juliana Poonoosamy, Philippe Lopes, Priscille Huret, Randa Dardari, Alfred Penfornis, Claire Thomas, Dured Dardari

Pharmaceutics · 22.06.2023 · 15 (7) · 1791

DOI: 10.3390/pharmaceutics15071791 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 22.06.2023. Verfasst von Juliana Poonoosamy und 6 weiteren Autor:innen. Beteiligte Einrichtung: LBEPS, IRBA, Université Paris Saclay, 91025 Evry, France. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes complications can be related to the long duration of the disease or chronic hyperglycemia. The follow-up of diabetic patients is based on the control of chronic hyperglycemia, although this correction, if obtained rapidly in people living with severe chronic hyperglycemia, can paradoxically interfere with the disease or even induce complications. We reviewed the literature describing the impact of the rapid and intense treatment of hyperglycemia on diabetic complications. The literature review showed that worsening complications occurred significantly in diabetic microangiopathy with the onset of specific neuropathy induced by the correction of diabetes. The results for macroangiopathy were somewhat mixed with the intensive and rapid correction of chronic hyperglycemia having a neutral impact on stroke and myocardial infarction but a significant increase in cardiovascular mortality. The management of diabetes has now entered a new era with new therapeutic molecules, such as gliflozin for patients living with type 2 diabetes, or hybrid insulin delivery systems for patients with insulin-treated diabetes. Our manuscript provides evidence in support of these personalized and progressive algorithms for the control of chronic hyperglycemia.

Schlagwörter

Stichwörter der Autor:innen

HbA1ccardiovascular eventsmicro- and macrovascular diabetes complicationstype 2 diabetes

Autor:innen und Institutionen

  • LBEPS, IRBA, Université Paris Saclay, 91025 Evry, France.
  • Al Fourkan Diabetes Center, Al Fourkan, Aleppo, Syria.
  • Diabetology Department, Centre Hopitalier Sud Francilien, 91100 Corbeil-Essonnes, France.
  • Paris-Sud Medical School, Paris-Saclay University, 91100 Corbeil-Essonnes, France.

Zitieren

APA

Poonoosamy, J., Lopes, P., Huret, P., Dardari, R., Penfornis, A., Thomas, C., & Dardari, D. (2023). Impact of Intensive Glycemic Treatment on Diabetes Complications—A Systematic Review. Pharmaceutics, 15(7), 1791. https://doi.org/10.3390/pharmaceutics15071791

Vancouver

Poonoosamy J, Lopes P, Huret P, Dardari R, Penfornis A, Thomas C, et al. Impact of Intensive Glycemic Treatment on Diabetes Complications—A Systematic Review. Pharmaceutics. 2023;15(7):1791. doi:10.3390/pharmaceutics15071791

BibTeX
@article{Poonoosamy2023,
  author = {Poonoosamy, Juliana and Lopes, Philippe and Huret, Priscille and Dardari, Randa and Penfornis, Alfred and Thomas, Claire and Dardari, Dured},
  title = {Impact of Intensive Glycemic Treatment on Diabetes Complications—A Systematic Review},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {7},
  pages = {1791},
  doi = {10.3390/pharmaceutics15071791}
}
Kostenlos starten →